Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2419 | 4143 | 31.7 | 72% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
73 | 3 | MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS | 82747 |
2419 | 2 | FEBRILE NEUTROPENIA//NEUTROPENIA//PEGFILGRASTIM | 4143 |
1343 | 1 | FEBRILE NEUTROPENIA//NEUTROPENIA//NEUTROPENIC FEVER | 2706 |
7855 | 1 | PEGFILGRASTIM//FEBRILE NEUTROPENIA//FILGRASTIM | 1320 |
34054 | 1 | BUSH FOOD//AUSTRALIAN NATIVE FRUITS//LEMON ASPEN | 117 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | authKW | 2593977 | 13% | 68% | 520 |
2 | NEUTROPENIA | authKW | 1027874 | 15% | 23% | 601 |
3 | PEGFILGRASTIM | authKW | 815310 | 3% | 76% | 145 |
4 | FILGRASTIM | authKW | 379469 | 3% | 40% | 129 |
5 | NEUTROPENIC FEVER | authKW | 191787 | 1% | 48% | 54 |
6 | CHEMOTHERAPY INDUCED NEUTROPENIA | authKW | 150699 | 1% | 68% | 30 |
7 | GRANULOCYTE COLONY STIMULATING FACTOR | authKW | 131216 | 4% | 11% | 164 |
8 | G CSF | authKW | 127238 | 4% | 10% | 174 |
9 | FEVER AND NEUTROPENIA | authKW | 113680 | 0% | 86% | 18 |
10 | FEVER | authKW | 84078 | 4% | 6% | 183 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 26369 | 42% | 0% | 1725 |
2 | Infectious Diseases | 18108 | 20% | 0% | 833 |
3 | Hematology | 14964 | 19% | 0% | 779 |
4 | Microbiology | 3307 | 13% | 0% | 538 |
5 | Health Care Sciences & Services | 2952 | 6% | 0% | 253 |
6 | Pediatrics | 2469 | 9% | 0% | 385 |
7 | Medicine, General & Internal | 1987 | 12% | 0% | 479 |
8 | Pharmacology & Pharmacy | 1926 | 15% | 0% | 614 |
9 | Transplantation | 1885 | 5% | 0% | 199 |
10 | Rehabilitation | 1601 | 4% | 0% | 185 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IMMUNOCOMPROMISED HOST DIS UNIT | 29474 | 0% | 100% | 4 |
2 | HLTH SERV OUTCOMES PROGRAM | 22105 | 0% | 100% | 3 |
3 | REIPI SPANISH NETWORK INFECT DIS | 20464 | 0% | 56% | 5 |
4 | ECPM EXECUT OFF | 16578 | 0% | 75% | 3 |
5 | PEDIAT ADOLESCENT COMPARAT EFFECTIVENESS | 16578 | 0% | 75% | 3 |
6 | TEVA RATIOPHARM | 16578 | 0% | 75% | 3 |
7 | HUTCHINSON CANC OUTCOMES | 15022 | 0% | 20% | 10 |
8 | CIBE INVEST BIOMED RED ENFERMEDADES P | 14737 | 0% | 100% | 2 |
9 | GRP ONCOL COOPERAT CHILENO INVEST | 14737 | 0% | 100% | 2 |
10 | HOSP CONTROL | 14737 | 0% | 100% | 2 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SUPPORTIVE CARE IN CANCER | 50793 | 4% | 4% | 172 |
2 | BONE MARROW TRANSPLANTATION | 16242 | 3% | 2% | 140 |
3 | PEDIATRIC HEMATOLOGY AND ONCOLOGY | 8991 | 1% | 2% | 50 |
4 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 8752 | 3% | 1% | 123 |
5 | JOURNAL OF CLINICAL ONCOLOGY | 7504 | 3% | 1% | 130 |
6 | INFECTION | 7448 | 1% | 2% | 62 |
7 | PEDIATRIC BLOOD & CANCER | 7000 | 2% | 1% | 66 |
8 | CHEMOTHERAPY | 5810 | 1% | 2% | 45 |
9 | SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 5676 | 2% | 1% | 64 |
10 | INDIAN JOURNAL OF CANCER | 5386 | 1% | 3% | 22 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FEBRILE NEUTROPENIA | 2593977 | 13% | 68% | 520 | Search FEBRILE+NEUTROPENIA | Search FEBRILE+NEUTROPENIA |
2 | NEUTROPENIA | 1027874 | 15% | 23% | 601 | Search NEUTROPENIA | Search NEUTROPENIA |
3 | PEGFILGRASTIM | 815310 | 3% | 76% | 145 | Search PEGFILGRASTIM | Search PEGFILGRASTIM |
4 | FILGRASTIM | 379469 | 3% | 40% | 129 | Search FILGRASTIM | Search FILGRASTIM |
5 | NEUTROPENIC FEVER | 191787 | 1% | 48% | 54 | Search NEUTROPENIC+FEVER | Search NEUTROPENIC+FEVER |
6 | CHEMOTHERAPY INDUCED NEUTROPENIA | 150699 | 1% | 68% | 30 | Search CHEMOTHERAPY+INDUCED+NEUTROPENIA | Search CHEMOTHERAPY+INDUCED+NEUTROPENIA |
7 | GRANULOCYTE COLONY STIMULATING FACTOR | 131216 | 4% | 11% | 164 | Search GRANULOCYTE+COLONY+STIMULATING+FACTOR | Search GRANULOCYTE+COLONY+STIMULATING+FACTOR |
8 | G CSF | 127238 | 4% | 10% | 174 | Search G+CSF | Search G+CSF |
9 | FEVER AND NEUTROPENIA | 113680 | 0% | 86% | 18 | Search FEVER+AND+NEUTROPENIA | Search FEVER+AND+NEUTROPENIA |
10 | FEVER | 84078 | 4% | 6% | 183 | Search FEVER | Search FEVER |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | GAFTER-GVILI, A , FRASER, A , PAUL, M , VIDAL, L , LAWRIE, TA , VAN DE WETERING, MD , KREMER, LCM , LEIBOVICI, L , (2012) ANTIBIOTIC PROPHYLAXIS FOR BACTERIAL INFECTIONS IN AFEBRILE NEUTROPENIC PATIENTS FOLLOWING CHEMOTHERAPY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 1. P. - | 138 | 91% | 11 |
2 | HUGHES, WT , ARMSTRONG, D , BODEY, GP , BOW, EJ , BROWN, AE , CALANDRA, T , FELD, R , PIZZO, PA , ROLSTON, KVI , SHENEP, JL , ET AL (2002) 2002 GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH CANCER.CLINICAL INFECTIOUS DISEASES. VOL. 34. ISSUE 6. P. 730 -751 | 103 | 71% | 1090 |
3 | FREIFELD, AG , BOW, EJ , SEPKOWITZ, KA , BOECKH, MJ , ITO, JI , MULLEN, CA , RAAD, II , ROLSTON, KV , YOUNG, JAH , WINGARD, JR , (2011) CLINICAL PRACTICE GUIDELINE FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH CANCER: 2010 UPDATE BY THE INFECTIOUS DISEASES SOCIETY OF AMERICA.CLINICAL INFECTIOUS DISEASES. VOL. 52. ISSUE 4. P. E56 -E93 | 118 | 42% | 536 |
4 | HUGHES, WT , ARMSTRONG, D , BODEY, GP , BROWN, AE , EDWARDS, JE , FELD, R , PIZZO, P , ROLSTON, KVI , SHENEP, JL , YOUNG, LS , (1997) 1997 GUIDELINES FOR THE USE OF ANTIMICROBIAL AGENTS IN NEUTROPENIC PATIENTS WITH UNEXPLAINED FEVER.CLINICAL INFECTIOUS DISEASES. VOL. 25. ISSUE 3. P. 551-573 | 124 | 78% | 422 |
5 | GAFTER-GVILI, A , FRASER, A , PAUL, M , VAN DE WETERING, M , KREMER, L , LEIBOVICI, L , (2005) ANTIBIOTIC PROPHYLAXIS FOR BACTERIAL INFECTIONS IN AFEBRILE NEUTROPENIC PATIENTS FOLLOWING CHEMOTHERAPY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 121 | 90% | 13 |
6 | GAFTER-GVILI, A , FRASER, A , PAUL, M , LEIBOVICI, L , (2005) META-ANALYSIS: ANTIBIOTIC PROPHYLAXIS REDUCES MORTALITY IN NEUTROPENIC PATIENTS.ANNALS OF INTERNAL MEDICINE. VOL. 142. ISSUE 12. P. 979-995 | 88 | 94% | 214 |
7 | VIDAL, L , BEN DOR, I , PAUL, M , ELIAKIM-RAZ, N , POKROY, E , SOARES-WEISER, K , LEIBOVICI, L , (2013) ORAL VERSUS INTRAVENOUS ANTIBIOTIC TREATMENT FOR FEBRILE NEUTROPENIA IN CANCER PATIENTS.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 10. P. - | 87 | 99% | 3 |
8 | FLOWERS, CR , SEIDENFELD, J , BOW, EJ , KARTEN, C , GLEASON, C , HAWLEY, DK , KUDERER, NM , LANGSTON, AA , MARR, KA , ROLSTON, KVI , ET AL (2013) ANTIMICROBIAL PROPHYLAXIS AND OUTPATIENT MANAGEMENT OF FEVER AND NEUTROPENIA IN ADULTS TREATED FOR MALIGNANCY: AMERICAN SOCIETY OF CLINICAL ONCOLOGY CLINICAL PRACTICE GUIDELINE.JOURNAL OF CLINICAL ONCOLOGY. VOL. 31. ISSUE 6. P. 794-810 | 80 | 65% | 106 |
9 | SKOETZ, N , BOHLIUS, J , ENGERT, A , MONSEF, I , BLANK, O , VEHRESCHILD, JJ , (2015) PROPHYLACTIC ANTIBIOTICS OR G(M)-CSF FOR THE PREVENTION OF INFECTIONS AND IMPROVEMENT OF SURVIVAL IN CANCER PATIENTS RECEIVING MYELOTOXIC CHEMOTHERAPY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 12. P. - | 87 | 79% | 0 |
10 | WEBER, DC , ZIELINSKI, C , AAPRO, MS , BOHLIUS, J , CAMERON, DA , DAL LAGO, L , DONNELLY, JP , KEARNEY, N , LYMAN, GH , PETTENGELL, R , ET AL (2011) 2010 UPDATE OF EORTC GUIDELINES FOR THE USE OF GRANULOCYTE-COLONY STIMULATING FACTOR TO REDUCE THE INCIDENCE OF CHEMOTHERAPY-INDUCED FEBRILE NEUTROPENIA IN ADULT PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS AND SOLID TUMOURS.EUROPEAN JOURNAL OF CANCER. VOL. 47. ISSUE 1. P. 8 -32 | 92 | 44% | 306 |
Classes with closest relation at Level 2 |